speaker-photo

Jaume Mora 🇪🇸

scientific director of the Pediatric Cancer Center Barcelona (PCCB) at HSJD
a pediatric oncologist with a PhD in Molecular Oncology since 2003. After residency training in general pediatrics (1992-1995)

13:20 -13:40

Sunday, 13 April 2025 Track 2

Advances in Neuroblastoma treatment

14:00 - 14:20

Sunday, 13 April 2025 Track 2

Inpharmous- Humanized Anti-GD2 Naxitamab: A New Era for High-Risk Neuroblastoma Patients